Press Release

Transfection reagents and equipment Market worth $1,496.43 million in 2026

September, 2020

" Transfection reagents and equipment market, size, share, growth, and forecast 2020-2027 "

Transfection plays a vital role in producing biological molecules by facilitating explorative analysis and bio-reliability studies for biopharmaceuticals’ regulatory approvals. Since, the growing preference for biopharmaceuticals resulted in phenomenal growth of technology in terms of demand as well as sales.

The Market of Transfection Reagents and Equipment is estimated to gain USD 1,496.43 million by 2026, growing at a CAGR of 7.7% from 2020 to 2026.

Technological advancements to introduce the enhanced techniques for stable and transient transfection with negligible off-target effects are projected to obtain high results in the market during the forecast period. For instance, Life Technologies has introduced Lipofectamine, a lipid-based formulation for nucleic acid delivery, which intensifies cell capable of survivability and reproducibility throughout the transfection process of hard to transfect cell lines by optimization in different steps of transfection.

Request for sample report @

The market report titled “Transfection Reagents and Equipment Market By Product, By Method, By Application, By End-User and By Geography – Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026 provide the foundation for Transfection reagents and equipment, vendor capabilities, various dynamics and framework for data analysis for further advanced innovations. The competitive outlook is described by the report which is an absolute need for having the required innovations with least of the investments.

The study also includes the analysis of major players in the Transfection Reagents and Equipment market. Some of the major players consist of Thermo Fisher Scientific Inc, PROMEGA CORPORATION, Qiagen N.V, F. Hoffmann-La Roche Ltd, Inc, Maxcyte, Inc, Lonza Group Ltd, Polyplus-Transfection Sa, Bio–Rad Laboratories, Merck KGaA, and Mirus Bio LLC.

Due to the well-developed genomic industries present in North America and lot of utilization of transfection technologies and also the existence of dominant players which come up with advanced solutions are the reasons which are making the North America a dominant region in this market.

Access full report summary @

The scope of the Transfection Reagents and Equipment Market is defined in the market analysis as follows:

  • Based on Product
    • Reagents
    • Instruments
  • Based on Method
    • Biochemical
    • Calcium Phosphate
    • Lipofection
    • DEAE-dextran
    • Dendrimers
    • Physical
    • Electroporation
    • Nucleofection
    • Others (Genegun, Sonoporation, Magnetofection, and Optoinjection)
    • Viral
  • Based on Application
    • Biomedical Research
    • Gene Expression Studies
    • Cancer Research
    • Transgenic Model
    • Protein Production
    • Therapeutic Delivery
  • Based on End-User
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies 
  • Based on Geography:
    • North America
    • Europe
    • Asia Pacific
    • Rest of World

Mr. Karthick Subramani

Infoholic Research LLP

Marketing & Communication